This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Mitchell, J. M. et al. MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nat. Med. https://doi.org/10.1038/s41591-021-01336-3 (2021).
Halvorsen, J. Ø. et. al. Nat. Med. doi (2021).
Burke, M. J. et. al. Nat. Med. doi (2021).
Feduccia, A. A. et al. Breakthrough for trauma treatment: safety and efficacy of MDMA-assisted psychotherapy compared to paroxetine and sertraline. Front. Psychiatry September 2019, 1–7 (2019).
Jerome, L. et al. Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials. Psychopharmacol. 237, 2485–2497 (2020).
American Psychological Association. Clinical Practice Guideline for the Treatment of Posttraumatic Stress Disorder (PTSD) in Adults 1st edn (APA, 2017).
Author information
Authors and Affiliations
Contributions
J. M., A. C. and B. Y.-K. contributed to the writing of this manuscript.
Corresponding author
Ethics declarations
Competing interests
A. C. and B. Y.-K. received salary support for full-time employment with MAPS PBC/MAPS, the trial organizer and sponsor.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Mitchell, J., Coker, A. & Yazar-Klosinski, B. Reply to: Caution at psychiatry’s psychedelic frontier and Challenges with benchmarking of MDMA-assisted psychotherapy. Nat Med 27, 1691–1692 (2021). https://doi.org/10.1038/s41591-021-01526-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-021-01526-z
This article is cited by
-
MDMA-assisted psychotherapy for PTSD in adolescents: rationale, potential, risks, and considerations
European Child & Adolescent Psychiatry (2023)